isopentenyladenosine has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avilia, G; Bifulco, M; Caiazzo, P; Chiariotti, L; Coppola, L; Corsaro, A; Della Monica, R; Florio, T; Gazzerro, P; Laezza, C; Navarra, G; Pagano, C; Pastorino, O; Torelli, G | 1 |
| Bifulco, M; Casapullo, A; Ciaglia, E; Gazzerro, P; Giacomini, A; Laezza, C; Malfitano, AM; Margarucci, L; Picardi, P; Pisanti, S; Ronca, R | 1 |
2 other study(ies) available for isopentenyladenosine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
N6-Isopentenyladenosine Hinders the Vasculogenic Mimicry in Human Glioblastoma Cells through Src-120 Catenin Pathway Modulation and RhoA Activity Inhibition.
Topics: Antigens, CD; Cadherins; Catenins; Cell Line, Tumor; Glioblastoma; Humans; Isopentenyladenosine; Neovascularization, Pathologic; rhoA GTP-Binding Protein; Signal Transduction; src-Family Kinases | 2021 |
Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation.
Topics: AMP-Activated Protein Kinases; Angiogenesis Inhibitors; Chromatography, Liquid; Enzyme Activation; Human Umbilical Vein Endothelial Cells; Humans; Isopentenyladenosine; Neovascularization, Pathologic; Phosphorylation; Tandem Mass Spectrometry | 2014 |